Cawachi Limited

2664.T
Pharmaceutical Retailers
2026/10/29 11:49 Updated
Market Cap: $561.0M (¥88.6B)
Stock Price: $25.73 (¥4,065)
Exchange Rate: 1 USD = ¥157.98

Notice of Revision to Full-Year Earnings Guidance

Revised the consolidated full-year earnings guidance for the fiscal year ending March 2027. Net sales were revised downward from the previous forecast of 285,000 hundred million yen to 283,000 hundred million yen, a downward revision of 2,000 hundred million yen (▲0.7%). Operating income and ordinary income remain unchanged at 5,100 million yen and 6,000 million yen, respectively. Net income attributable to owners of parent remains unchanged at 3,000 million yen, and earnings per share increased slightly to 136.14 yen.

Importance:
Page Updated: October 28, 2026
IR Disclosure Date: October 28, 2026

Key Figures

  • Net sales: 283,000 hundred million yen (previous forecast 285,000 hundred million yen → revised)
  • Operating income: 5,100 million yen (same as previous forecast)
  • Ordinary income: 6,000 million yen (same as previous forecast)

AI要約

Overview of the Revision to Earnings Guidance

The full-year revision announced today concerns the consolidated earnings guidance for the fiscal year ending March 2027. Net sales are revised downward by 0.7% to 283,000 hundred million yen compared with the previous forecast, while operating income and ordinary income are expected to remain unchanged. Net income attributable to owners of parent and earnings per share remain at 3,000 million yen and 136.14 yen, respectively. The primary reason for the downward revision is a judgment based on results for the interim consolidated period and anticipated future conditions.

Background and Future Outlook

During the interim consolidated period, sales of seasonal products were weak due to adverse weather, while reductions in personnel expenses and utilities helped support profitability by controlling selling, general and administrative expenses. In light of this, net sales are expected to fall short of plan, prompting the revision to the full-year forecast. The company notes the impact of external factors such as foreign exchange, and future results remain subject to uncertainty.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Cawachi Limited

Company overview · Stock price · Financial data · All IR

View company page →